Chemistry 1 H NMR spectra were recorded on either a Bruker Avance DPX 500 or on a Bruker Avance 300 spectrometer. Chemical shifts (δ) are expressed in ppm. Signal splitting patterns are described as singlet (s), broad singlet (bs), doublet (d), triplet (t), quartet (q), multiplet (m) or combinations thereof. LC-MS analyses were performed with either an Agilent HPLC 1100 series connected to a Bruker Daltonics MicrOTOF, or an Agilent Technologies 1200 series HPLC connected to an Agilent Technologies 6130 quadrupole LC/MS, both instruments were connected to an Agilent diode array detector. LCMS chromatographic separations were conducted with a Phenomenex Gemini C18 column, 50 × 3.0 mm, 5 μm particle size; mobile phase, water / acetonitrile + 0.1% HCOOH 80:20 to 5:95 over 3.5 min, and then held for 1.5 min; flow rate 0.5 ml min -1 . High resolution electrospray measurements were performed on a Bruker Daltonics MicrOTOF mass spectrometer. Thin layer chromatography (TLC) was carried out on Merck silica gel 60 F254 plates using UV light and / or KMnO 4 for visualization.
ethanol. The reaction was stirred at 20°C for 18 h and concentrated, washed, then concentrated again to afford a cream coloured solid. The crude product was purified by flash column chromatography (6% methanol / dichloromethane eluant), to yield compound 11 as a white solid (512 mg, 47%). 1 H NMR and LCMS confirmed purity at >98%. 1 
1-(3,5-Dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (12)
Prepared as for compound 7, starting from 2-aminobenzimidazole (2) (500 mg, 3.76 mmol), potassium hydroxide flakes (317 mg, 5.64 mmol) and 3,5-dichlorobenzyl chloride (772 mg, 3.95 mmol) in 15 ml ethanol The reaction was stirred at 20°C for 18 h and concentrated, washed, then concentrated again.
The crude product was purified by flash column chromatography (6% methanol / dichloromethane eluant), to yield compound 12 as a white solid (700 mg, 64%). 1 H NMR and LCMS confirmed purity at >98%. 1 
1-(Pyridin-2-ylmethyl)-1H-benzo[d]imidazol-2-amine (19)
Prepared as for compound 7, starting from 2-aminobenzimidazole (2) (500 mg, 3.76 mmol), potassium hydroxide flakes (317 mg, 5.64 mmol) and 2-(bromomethyl)pyridine hydrobromide salt (999 mg, 3.95 mmol) in 15 ml ethanol. The reaction was stirred at 20°C for 18 h and concentrated, washed, then concentrated again. The crude product was purified by flash column chromatography (10% methanol / dichloromethane eluant), to yield compound 19 as a white solid (615 mg, 73%). 1 
H NMR and LCMS
confirmed purity at >98%. 1 
1-(Pyridin-3-ylmethyl)-1H-benzo[d]imidazol-2-amine (20)
Prepared as for compound 7, starting from 2-aminobenzimidazole (2) (500 mg, 3.76 mmol), potassium hydroxide flakes (317 mg, 5.64 mmol) and 3-(bromomethyl)pyridine hydrobromide salt (999 mg, 3.95 mmol) in 15 ml ethanol. The reaction was stirred at 20°C for 18 h and concentrated, washed, then concentrated again. The crude product was purified by flash column chromatography (10% methanol / dichloromethane eluant), to yield compound 20 as a white solid (550 mg, 65%). 1 
1-(Naphthalen-1-ylmethyl)-1H-benzo[d]imidazol-2-amine (21) [7]
Prepared as for compound 7, starting from 2-aminobenzimidazole (2) (500 mg, 3.76 mmol), potassium hydroxide flakes (317 mg, 5.64 mmol) and 1-(bromomethyl)naphthalene (873 mg, 3.95 mmol) in 10 ml ethanol. The reaction was stirred at 20°C for 18 h and concentrated, washed, then concentrated again.
The crude product was purified by flash column chromatography (6% methanol / dichloromethane eluant), to yield compound 21 as a beige solid (570 mg, 55%). 1 
1-(Naphthalen-2-ylmethyl)-1H-benzo[d]imidazol-2-amine (22)
Prepared as for compound 7, starting from 2-aminobenzimidazole (2) (500 mg, 3.76 mmol), potassium hydroxide flakes (317 mg, 5.64 mmol) and 2-(bromomethyl)naphthylene (873 mg, 3.95 mmol) in 15 ml ethanol. The reaction was stirred at 20°C for 18 h and concentrated, washed, then concentrated again.
The crude product was purified by flash column chromatography (6% methanol / dichloromethane eluant), to yield compound 22 as a cream coloured solid (810 mg, 79%). 1 
N-(1-(3,4-Dichlorobenzyl)-1H-benzo[d]imidazol-2-yl)acetamide (23)
1-(3,4-dichlorobenzyl)-1H-benzo(d)imidazol-2-amine (11) (150 mg, 0.514 mmol) was taken into ethylacetate (10 ml), and acetic anhydride (115 mg, 1.13 mmol) was added dropwise . The reaction was stirred at 20°C for 18 h and then heated to 60°C for 2 h. On cooling the reaction a white solid crystallised out, this was collected by filtration, and washed with ethylacetate (2x5 ml) to yield compound 23 as a white solid (52 mg, 30%). 1 H NMR and LCMS confirmed purity at >98%. 1 
4-Chloro-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (24)
Prepared as for compound 7, starting from 7-chloro-1H-benzo[d]imidazol-2-amine (41) (200 mg, 1.19 mmol), potassium hydroxide flakes (100 mg, 1.79 mmol) and 3,4-dichlorobenzyl chloride (244 mg, 1.25 mmol) in 15 ml ethanol. The reaction was stirred at 20°C for 48 h and concentrated, washed, then concentrated again. The product was purified by flash column chromatography (3% methanol/ dichloromethane eluant), to yield compound 24 as white solid (60 mg, 15%). 1 
H NMR and LCMS
confirmed purity at >98%.
The relative 1 H NMR signal for the CH 2 -dichlorobenzyl protons at 5.28 ppm, versus 5.54 ppm for compound 29, agrees with the expected shift for a 4-substituted N1-benzylated benzimidazole versus a 7-substituted benzimidazole. This observed relative shift is supported by the literature. [8] 1 H NMR (500 MHz, DMSO): δ = 5.28 (2H, s, CH 2 ), 6.82 (1H, t J=7.9Hz, ArH), 6.91 (2H, s, NH 2 ), 
4-( n Propyloxy)-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (25)
Prepared as for compound 7, starting from 7-( n propyloxy)-1H-benzo[d]imidazol-2-amine (43) (250 mg, 1.31 mmol), potassium hydroxide flakes (110 mg, 6.28 mmol) and 3,4-dichlorobenzyl chloride (269 mg, 1.38 mmol) in 10 ml ethanol. The reaction was stirred at 20°C for 48 h and concentrated, washed, then concentrated again. The product was purified by flash column chromatography (10% methanol / dichloromethane eluant), to yield compound 25 as white solid (65 mg, 14%). 1 
4-(Benzyloxy)-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (26)
The crude filtrate from example 31 containing the 4-(benzyloxy)-1-(3,4-dichlorobenzyl)-1Hbenzo[d]imidazol-2-amine was purified by flash column chromatography (6% methanol / dichloromethane eluant), to yield compound 26 as white solid (450 mg, 27%). The weight balance was also collected (500 mg mixture of compounds 31 and 26). 1 
4-Methoxy-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (28)
Prepared as for compound 7, starting from 7-(methoxy)-1H-benzo[d]imidazol-2-amine (46) (200 mg, 1.23 mmol), potassium hydroxide flakes (104 mg, 1.85 mmol) and 3,4-dichlorobenzyl chloride (252 mg, 1.29 mmol) in 10 ml ethanol. The reaction was stirred at 20°C for 48 h and concentrated, washed, then concentrated again. The reaction mixture was then purified by reverse phase prep HPLC (gradient:
20% acetonitrile/water to 80% acetonitrile/water, 9.2 mmol column packed with C18 silica). NB with normal phase silica chromatography no separation of isomers is seen. Unfortunately the compound 28 obtained still contains 25% contaminant of the 7-methoxy isomer (compound 33). 1 H NMR and LCMS confirmed purity at 75% (isomer ratio 3:1 (28 : 33)).
Absolute regiochemistry of compound 28 was confirmed by the relative 1 
7-Chloro-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (29)
Compound 29 was obtained from the crude product mixture of reaction 24. Compound 29 was the more polar product obtained purified by flash column chromatography (10% methanol/ dichloromethane eluant), yielded compound 29 as a white solid (68 mg, 17%). 1 
7-(Benzyloxy)-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (31)
Prepared as for compound 7, starting from 7-(benzyloxy)-1H-benzo[d]imidazol-2-amine (37) (1g, 4.18 mmol), potassium hydroxide flakes (325 mg, 6.28 mmol) and 3,4-dichlorobenzyl chloride (858 mg, 4.39 mmol) in 15 ml ethanol. The reaction was stirred at 20°C for 48 h. The resulting precipitated product was filtered off to yield compound 31 as white solid (350 mg, 21%). 1 
H NMR and LCMS
Absolute regiochemistry of compound 31 was confirmed by NOESY NMR: a strong interaction between CH 2 -dichlorobenzyl protons at 5.40 ppm (2H, s, CH 2 ) and the 7-OCH 2 -benzyl signal at 5.08 ppm (2H, s, CH 2 ) was observed, indicating close proximity of these substituents. Also, the relative 1 H NMR signal for the CH 2 -dichlorobenzyl protons at 5.40 ppm, versus 5.27 ppm for compound 31, agrees with the expected shift for a 7-substituted N1-benzylated benzimidazole versus a 4-substituted benzimidazole. This observed relative shift is supported by the literature. [8] Compound 26 (along with a second batch of compound 31) was obtained from the filtrate by flash column chromatography. 1 
7-Phenyl-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (32)
Compound 32 was obtained from the crude product mixture of reaction 27. Compound 32 was the more polar product obtained purified by flash column chromatography (10% methanol / dichloromethane eluant), collected as a white solid (35 mg, 18%). 1 
7-Methoxy-1-(3,4-dichlorobenzyl)-1H-benzo[d]imidazol-2-amine (33)
As above (example 28), compound 33 was obtained by reverse phase prep HPLC (gradient: 20% acetonitrile/water to 80% acetonitrile/water, 9.2 mmol column packed with C18 silica). Compound 33 was the second isomer to elute off the HPLC column, and was obtained with 1 H NMR and LCMS purity at >99% (as 7-methoxy stereoisomer). Compound 33 was obtained as a white solid, yield 10 mg.
Absolute regiochemistry of compound 33 was confirmed by the relative 1 H NMR signal for the CH 2dichlorobenzyl protons at 5.38 ppm for compound 33, versus 5.21 ppm for compound 28. This agrees with the expected shift for a 7-alkoxy substituted N1-benzylated benzimidazole versus a 4-substituted benzimidazole. This observed relative shift is supported by the confirmed regiochemistry of benzyloxysubstituted compounds 26 and 31, and the literature. 
1-(3,4-Dichlorobenzyl)-5,6-dimethyl-1H-benzo[d]imidazol-2-amine (34)
Prepared as for compound 7, starting from 5,6-dimethyl-2-aminobenzimidazole (1) (500 mg, 3.13 mmol), potassium hydroxide flakes (263 mg, 4.69 mmol) and 3,4-dichlorobenzyl chloride (643 mg, 3.29 mmol) in 15 ml ethanol. The reaction was stirred at 20°C for 18 h and concentrated, washed, then concentrated again. The crude product was purified by flash column chromatography (6% methanol/ dichloromethane eluant), to yield compound 34 as a white solid (670 mg, 67%). 1 H NMR and LCMS confirmed purity at >98%.
7-Phenyl-1H-benzo[d]imidazol-2-amine (35)
To a solution of biphenyl-2,3-diamine, compound 36 (350 mg, 1.9 mmol), in acetonitrile (18 ml) and water (4 ml) was added cyanogenbromide 2M solution in acetonitrile (1.05 ml, 2.09 mmol). The reaction was stirred at 20°C for 18 h, and concentrated to remove the acetonitrile. Ethyl acetate (40 ml) and sodium bicarbonate solution (1x40 ml) were added, and the biphasic solution was transferred to a separating funnel. The organic layer was washed with water (1x25 ml), sodium bicarbonate solution (1x20 ml) and brine (2x30 ml), before being dried with magnesium sulfate and concentrated to remove 
Biphenyl-2,3-diamine (36)
Prepared as for compound 47, using 3-phenyl-2-nitroaniline, compound 40 (500 mg, 2.34 mmol), tin(II) chloride (2.2g, 11.7 mmol) in ethanol 25 ml). The reaction was heated in a microwave reactor at 140°C for 10 min then worked up as previously described. The solution was concentrated to remove ethyl acetate, affording compound 36 in quantitative yield, as a colourless gum. LCMS confirmed purity at >95%. Used as 'crude' in example 35. 
LCMS (ES

7-(Benzyloxy)-1H-benzo[d]imidazol-2-amine (37)
Prepared as for compound 35, starting from 3-(benzyloxy)benzene-1,2-diamine, compound 38 (1.6g, 7.48 mmol), acetonitrile (30 ml), water (10 ml) and cyanogenbromide 2M solution in acetonitrile (4.12 ml, 8.23 mmol). The reaction was stirred at 20°C for 18 h, and concentrated to remove the acetonitrile.
Crude compound 37 was purified by flash column chromatography (8% methanol / dichloromethane eluant), yielded compound 37 as a white solid (1.1g, 61%). 1 
3-Benzyloxybenzene-1,2-diamine (38)
Prepared as for compound 47, using 2-benzyloxy-6-nitroaniline, compound 39 (935 mg, 3.83 mmol), tin(II) chloride (3.63g, 19.13 mmol) in ethanol (30 ml). The reaction was heated in a microwave reactor at 140°C for 10 min then worked up as previously described. The solution was concentrated to remove ethyl acetate, affording compound 38 in quantitative yield, as a yellow gum. LCMS confirmed purity at >95%. Used as 'crude' in example 37. 
LCMS (ES
2-Benzyloxy-6-nitroaniline (39)
Prepared as for compound 42, using 2-amino-3-nitrophenol (1g, 6.46 mmol), K 2 CO 3 (1.34g, 9. 
3-Phenyl-2-nitroaniline (40)
A solution of 2-phenylnitrobenzene (398 mg, 2 mmol) and o-methylhydroxylamine (118 mg, 2.5 mmol) in DMF (3 ml) was added dropwise (over 5 min) to a stirred suspension of t BuOK (672 mg, 6 mmol) and Cu(I)Cl (20 mg, 0.2 mmol) in DMF (7 ml). The reaction was stirred at 20°C for 60 min, and then quenched with ammonium chloride solution. The product was extracted into DCM, dried with 
3-Chlorobenzene-1,2-diamine (42)
Prepared as for compound 47, using 2-chloro-6-nitroaniline (1.0 g, 5.8 mmol), tin(II) chloride (5.5g, 29 mmol) in ethanol 30 ml). The reaction was heated in a microwave reactor at 140°C for 10 min then worked up as previously described. The solution was concentrated to remove ethyl acetate, affording compound 42 in quantitative yield, as a colourless gum. LCMS confirmed purity at >95%. Used as 'crude' in example 41. 
LCMS (ES
3-Methoxybenzene-1,2-diamine (47)
To a solution of 2-methoxy-6-nitroaniline, compound 48 (500 mg, 2.98 mmol) in ethanol (15 ml) was added tin(II) chloride (2.83g, 14.9 mmol). The reaction was heated in a microwave reactor at 140°C for 10 min. The reaction mixture was poured into NaHCO 3 solution (30 ml) and the product was extracted into ethyl acetate (2x25 ml). The organic layers were combined and washed with sodium bicarbonate solution (1x30 ml), water (1x30 ml) and brine (2x40 ml), before being dried with MgSO4 and concentrated to remove ethyl acetate. Afforded compound 47 as a pale yellow oil in quantitative yield. 1 H NMR and LCMS confirmed purity at >95%. 1 
2-Methoxy-6-nitroaniline (48)
To a stirred solution of 2-amino-3-nitrophenol (500 mg, 3.23 mmol) in DMF (15 ml) was added K 2 CO 3 (669 mg, 4.84 mmol) and methyl iodide (504 mg, 3.55 mmol). The reaction was stirred at 20°C for 12 h, then poured into NaHCO 3 solution (20 ml), and the product was extracted into ethyl acetate (2x30 ml). The organic layers were combined then washed with water (1x30 ml), sodium bicarbonate solution (1x30 ml) and brine (2x40 ml), before being dried with MgSO 4 and concentrated to remove ethyl acetate. Crude compound 48 was purified by flash column chromatography (3% methanol/ dichloromethane eluant), affording compound 48 as a yellow solid (520 mg, 96%). 1 
Enzyme Assays
Inhibitor sensitivity against PTR1 and DHFR were determined using the cytochrome-c coupled assay method. [9] . An HPLC method was used to determine the sensitivity of PTR1 to compound 32 in clarified cell lysates. Assays were carried out in 20 mM sodium citrate (pH 6.0) containing 1 mM EDTA, 1% (v/v) DMSO, 0.1% (v/v) Triton X-100 and 100 μM NADPH cofactor. TbPTR1 (1.1 nM) was preincubated with varying concentrations of compound 32 (0-1 µM) for 5 min, before reactions were initiated using 25 nM dihydrobiopterin. Aliquots (100 μl) of enzymatic reactions were removed after 2 min and oxidized with iodine under alkaline conditions and analysed by HPLC as previously described. [9] The IC 50 of 32 against native PTR1 in T. brucei clarified lysates (20,000 g, 30 min, 4 °C;
final assay concentration 100 µg ml -1 ) was determined in a similar fashion. Lysates were prepared [10] using T. brucei harvested from rats, [11] as previously described. Trypanothione reductase activity was measured in clarified lysates as previously described [12] to ensure adequate extraction of parasites.
Trypanosome Growth Assays
These were performed as previously described. [13] 
